Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Alix Capital names winners of first UCITS Alternative Index Awards

Monday, January 21, 2013
Opalesque Industry Update - Alix Capital, the Geneva-based provider of the UCITS Alternatives Index family of indices, has announced the winners of its inaugural UCITS Alternative Index (UAI) Awards. The awards, which will be held annually, honour the UCITS hedge funds that have returned the best performance over one and three year periods.

The UAI Awards cover 13 categories with two awards announced per category. The winners have been selected by a committee led by Louis Zanolin, CEO of Alix Capital, which oversees the award methodology.

The 2012 UAI Awards winners are as follows:

[1] There was no winner for the Best performing Commodities UCITS Hedge Funds three year award as there were fewer than ten funds meeting the criteria for that time period.


Louis Zanolin, CEO of Alix Capital, says: “As our latest quarterly UCITS Alternative Industry report shows, the UCITS hedge funds space continues to grow and evolve, with assets now totaling over EUR 140 billion, and we felt it was time to recognise the best performing funds in the alternative UCITS industry. UCITS hedge funds are increasingly becoming more and more attractive for investors, especially as they look for alternatives to offshore funds and the range of onshore options increases. We expect to see this recent growth trend persist as the industry adapts to new regulation and investment opportunities resulting from the changing economic landscape, which is constantly being reshaped.

“I would like to congratulate all the winners of the inaugural UCITS Alternative Index (UAI) Awards. Their performance has set them apart as the best performing funds and we wanted to acknowledge their achievements, not only looking at the past year, but also emphasising their performance over the longer term. I am confident that the UAI Awards will become an established industry award and a valid recognition of the best performing funds in the alternative UCITS industry.”

To qualify for the awards funds must be part of the UCITS Alternative Index Global or UCITS Alternative Index Fund of Funds, have at least 12 or 36 months of performance history and have at least EUR 10 million AUM.

Press release

www.ucits-alternative.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its